•1 min read•from TechCrunch
Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing
Our take
VITL is poised to transform the cash-pay clinic landscape with its recent $7.5 million funding round, capitalizing on the growing demand for GLP-1 medications. The startup offers an innovative e-prescribing marketplace designed specifically for cash-pay clinics, streamlining the prescribing process and enhancing patient access to essential treatments. As the market for these medications expands, VITL’s solution empowers clinics to provide more efficient care while navigating the complexities of modern healthcare.
The startup provides an e-prescribing marketplace for the booming cash-pay clinic market.
Read on the original site
Open the publisher's page for the full experience